Acinic cell carcinoma future or investigational therapies: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acinic cell carcinoma}} | {{Acinic cell carcinoma}} | ||
{{CMG}} {{AE}} {{RG}} | |||
==Overview== | ==Overview== | ||
Finding a good [[chemotherapy]] regimen for [[Metastasis|distant metastasis]], molecular methodology by the concept of MASC, links between genetic and disease, the role of [[S-100 protein]] in salivary gland pathologies are fields of further research. | |||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
* Finding a good [[Chemotherapy agent|chemotherapy]] regimen for distant [[metastasis]] is necessary, since far metastasis, specially lungs, have been involved in a great portion of patients.<ref name="Vander PoortenTriantafyllou2015">{{cite journal|last1=Vander Poorten|first1=V.|last2=Triantafyllou|first2=A.|last3=Thompson|first3=L. D. R.|last4=Bishop|first4=J.|last5=Hauben|first5=E.|last6=Hunt|first6=J.|last7=Skalova|first7=A.|last8=Stenman|first8=G.|last9=Takes|first9=R. P.|last10=Gnepp|first10=D. R.|last11=Hellquist|first11=H.|last12=Wenig|first12=B.|last13=Bell|first13=D.|last14=Rinaldo|first14=A.|last15=Ferlito|first15=A.|title=Salivary acinic cell carcinoma: reappraisal and update|journal=European Archives of Oto-Rhino-Laryngology|volume=273|issue=11|year=2015|pages=3511–3531|issn=0937-4477|doi=10.1007/s00405-015-3855-7}}</ref> | |||
* Molecular methodology by the concept of MASC need further thinking and research. | |||
* Links between genetic and disease is still uncertain. | |||
* The role of [[S-100 protein]] in salivary gland pathologies is still not very well understood. | |||
==References== | ==References== | ||
Latest revision as of 13:59, 4 October 2019
|
Acinic cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Acinic cell carcinoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Acinic cell carcinoma future or investigational therapies |
|
FDA on Acinic cell carcinoma future or investigational therapies |
|
CDC on Acinic cell carcinoma future or investigational therapies |
|
Acinic cell carcinoma future or investigational therapies in the news |
|
Blogs on Acinic cell carcinoma future or investigational therapies |
|
Risk calculators and risk factors for Acinic cell carcinoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
Finding a good chemotherapy regimen for distant metastasis, molecular methodology by the concept of MASC, links between genetic and disease, the role of S-100 protein in salivary gland pathologies are fields of further research.
Future or Investigational Therapies
- Finding a good chemotherapy regimen for distant metastasis is necessary, since far metastasis, specially lungs, have been involved in a great portion of patients.[1]
- Molecular methodology by the concept of MASC need further thinking and research.
- Links between genetic and disease is still uncertain.
- The role of S-100 protein in salivary gland pathologies is still not very well understood.
References
- ↑ Vander Poorten, V.; Triantafyllou, A.; Thompson, L. D. R.; Bishop, J.; Hauben, E.; Hunt, J.; Skalova, A.; Stenman, G.; Takes, R. P.; Gnepp, D. R.; Hellquist, H.; Wenig, B.; Bell, D.; Rinaldo, A.; Ferlito, A. (2015). "Salivary acinic cell carcinoma: reappraisal and update". European Archives of Oto-Rhino-Laryngology. 273 (11): 3511–3531. doi:10.1007/s00405-015-3855-7. ISSN 0937-4477.